-
Pharma CEO: Trust Me, Price-Gouging The Sick Is The Best Way To Help Them
Turing Pharma CEO Martin Shkreli has decided he will NOT drop the price of Daraprim.
-
Karma Strikes: Price-Gouging "Pharma Bro" Posts Loss Of $14 Million
Sometimes, there truly is karma in this world—that is, the idea that a person’s previous actions can decide his future fate. Turing Pharmaceuticals, the company owned by Martin Shkreli – who was dubbed the “pharma bro” after the despised CEO unapologetically raised the price of the company’s generic AIDS drug 5,000 percent overnight in September – reported…
-
House Dems: Republicans Are Blocking Us From Investigating Shkreli
They’re doing everything they can to protect this greedy price-gouging pharma CEO.
-
Price-Gouging Pharma CEO Fuming As Rival Creates $1 Alternative AIDS Drug
Well, this must be embarrassing for Martin Shkreli…
-
New York Launches Investigation Into Martin Shkreli's AIDS Drug Price-Gouging
Martin Shkreli, the CEO who jacked up the price of an AIDS drug by 5000%, is now under investigation by the NY Attorney General’s office.
-
Bernie To Greedy Price-Gouging Hedge-Funder: I'm Coming For You!
The costs of pharmaceutical drugs has been catapulted to the forefront of public discussion with the New York Times’ expose on vulture capitalist Martin Shkreli. His decision to buy the rights on an old drug and then raise the price by 5000% sparked a tsunami of outrage across social media and the political sphere, bringing to the national…